Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

Two Weill Cornell Medicine Faculty Members Inducted into ASCI

Two Weill Cornell Medicine physician-scientists, Dr. Randy Longman and Dr. Robert Schwartz, have been elected as members of the American Society for Clinical Investigation.

Biomedical Imaging Program Curriculum

The duration of the Program is 24 months. Each course is designed to be self-contained including development of the necessary mathematical formalism. Students will choose an advisor for their Master’s thesis research project by the end of the first spring semester. Research projects will be conducted over the final 15 months of the Program, including time to complete the thesis document. Students are required to defend their thesis orally to a thesis committee. 

2017-2020 Faculty Honors

Faculty and Research Awards Received by WCM Faculty Members 2017-2020

National Academy of Medicine

2020: Augustine Choi
Award details: To recognize exceptional professional excellence and achievement in a health-related field.

A New and Versatile Genetic Manipulation Pipeline for Studying Nonmodel Gut Bacteria

Scientists at the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine have developed a pipeline that enables genetic manipulation of nonmodel gut bacteria. The pipeline will allow scientists to study the biological roles of these bacteria, which are increasingly recognized as key factors in health and disease, at the single-gene level.

Researchers Identify Key Regulator of Blood Stem Cell Development

A protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body, according to a new study from researchers at Weill Cornell Medicine.

“Mini-Brains” Provide Clues About Early Life Origins of Schizophrenia

Multiple changes in brain cells during the first month of embryonic development may contribute to schizophrenia later in life, according to a new study by Weill Cornell Medicine investigators.

Researchers Identify Significant Differences in Tumor Characteristics Between Younger and Older Cancer Patients

Investigators at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types.

Their research, published Dec. 7 in Cell Reports, suggests that cancer treatment could potentially be tailored by age. The study also identified pre-existing drugs that could target mutations predominantly found in younger cancer patients—promising candidates for future clinical research.

Novel Immune Cell Population May Trigger Inflammation in Multiple Sclerosis and other Brain Disorders

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers. The results suggest that countering the activity of these cells could be a new therapeutic approach for such conditions.

Antibodies Help Keep Harmful Forms of Gut Fungi in Check

Antibody protection against harmful forms of fungi in the gut may be disrupted in some patients with Crohn’s disease—a condition caused by chronic inflammation in the bowel—according to a new study by Weill Cornell Medicine investigators.